MU Health Care pilots treatment for prostate cancer

News
MU Research Reactor

MU Health Care pilots treatment for prostate cancer

Published on Dec. 14, 2023

Treatment uses radioisotopes produced in the University of Missouri Research Reactor.

Dec. 13, 2023

University of Missouri Health Care has initiated its first treatment using an FDA-approved targeted radioactive medicine for advanced metastatic prostate cancer.